Clinical trial
Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
NCT00060086 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00060086 |
|---|---|
| Title | Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer |
| Official title | Phase II Study Evaluating Pomegranate Juice In Patients With Recurrent Adenocarcinoma Of The Prostate |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | POM Wonderful LLC Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement |
| Interventions | pomegranate juice |
| Enrollment | 47 |
| Start date | Nov 30, 2004 |
| Primary completion | May 25, 2021 |
| Completion | May 25, 2021 |
| First posted | May 7, 2003 |
| Last update posted | Jun 4, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: